These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 26721645)

  • 21. Ivabradine: Current and Future Treatment of Heart Failure.
    Thorup L; Simonsen U; Grimm D; Hedegaard ER
    Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):89-97. PubMed ID: 28371247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ivabradine: Do the Benefits Outweigh the Risks?
    Alshammari TM
    J Cardiovasc Pharmacol Ther; 2017 May; 22(3):210-218. PubMed ID: 27698078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy and safety analysis of ivabradine hydrochloride treatment of Chinese patients with chronic heart failure: subgroup analysis of Chinese patients in the SHIFT study].
    Hu DY; Huang DJ; Yuan ZY; Zhao RP; Yan XW; Wang MH;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Mar; 45(3):190-197. PubMed ID: 28316174
    [No Abstract]   [Full Text] [Related]  

  • 24. Ivabradine for the treatment of chronic heart failure.
    Henri C; O'Meara E; De Denus S; Elzir L; Tardif JC
    Expert Rev Cardiovasc Ther; 2016; 14(5):553-61. PubMed ID: 26967048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heart rate and its reduction in chronic heart failure and beyond.
    Nikolovska Vukadinović A; Vukadinović D; Borer J; Cowie M; Komajda M; Lainscak M; Swedberg K; Böhm M
    Eur J Heart Fail; 2017 Oct; 19(10):1230-1241. PubMed ID: 28627045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial).
    Böhm M; Robertson M; Ford I; Borer JS; Komajda M; Kindermann I; Maack C; Lainscak M; Swedberg K; Tavazzi L
    Am J Cardiol; 2015 Dec; 116(12):1890-7. PubMed ID: 26508709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preserved Autonomic Cardiovascular Regulation With Cardiac Pacemaker Inhibition: A Crossover Trial Using High-Fidelity Cardiovascular Phenotyping.
    Heusser K; Tank J; Brinkmann J; Schroeder C; May M; Großhennig A; Wenzel D; Diedrich A; Sweep FC; Mehling H; Luft FC; Jordan J
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26764413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel If current inhibitor ivabradine: safety considerations.
    Savelieva I; Camm AJ
    Adv Cardiol; 2006; 43():79-96. PubMed ID: 16936474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac and Hemodynamic Benefits: Mode of Action of Ivabradine in Heart Failure.
    Pereira-Barretto AC
    Adv Ther; 2015 Oct; 32(10):906-19. PubMed ID: 26521191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ivabradine: A Current Overview.
    Guha K; Allen CJ; Hartley A; Sharma R
    Curr Clin Pharmacol; 2016; 11(4):241-249. PubMed ID: 27784216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rate control with ivabradine: angina pectoris and beyond.
    Parakh N; Bhargava B
    Am J Cardiovasc Drugs; 2011; 11(1):1-12. PubMed ID: 21090826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT.
    Voors AA; van Veldhuisen DJ; Robertson M; Ford I; Borer JS; Böhm M; Komajda M; Swedberg K; Tavazzi L;
    Eur J Heart Fail; 2014 Apr; 16(4):426-34. PubMed ID: 24504937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of selective heart rate reduction through sinus node I
    Sisakian H; Sargsyan T; Khachatryan A
    Acta Cardiol; 2016 Jun; 71(3):317-22. PubMed ID: 27594127
    [No Abstract]   [Full Text] [Related]  

  • 34. Updates on HCN Channels in the Heart: Function, Dysfunction and Pharmacology.
    Sartiani L; Romanelli MN; Mugelli A; Cerbai E
    Curr Drug Targets; 2015; 16(8):868-76. PubMed ID: 26028050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heart rate reduction in heart failure: ivabradine or beta blockers?
    Guglin M
    Heart Fail Rev; 2013 Jul; 18(4):517-28. PubMed ID: 22972475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initiation of ivabradine in cardiogenic shock.
    Chiu MH; Howlett JG; Sharma NC
    ESC Heart Fail; 2019 Oct; 6(5):1088-1091. PubMed ID: 31332966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The efficacy of ivabradine in chronic heart failure (review)].
    Isakadze A; Makharadze T; Gvishiani M
    Georgian Med News; 2015 Apr; (241):44-9. PubMed ID: 25953938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.
    Kosmala W; Holland DJ; Rojek A; Wright L; Przewlocka-Kosmala M; Marwick TH
    J Am Coll Cardiol; 2013 Oct; 62(15):1330-8. PubMed ID: 23916925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benefits of Heart Rate Slowing With Ivabradine in Patients With Systolic Heart Failure and Coronary Artery Disease.
    Borer JS; Deedwania PC; Kim JB; Böhm M
    Am J Cardiol; 2016 Dec; 118(12):1948-1953. PubMed ID: 27780557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-Effectiveness of Ivabradine for Heart Failure in the United States.
    Kansal AR; Cowie MR; Kielhorn A; Krotneva S; Tafazzoli A; Zheng Y; Yurgin N
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27153871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.